Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 2681 of 3330
Next
>>
>
67001 to 67025 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
MDA-MB-415	HR+	Luminal	Sirolimus	MTOR	MTOR	0.267	uM	7510.068	0.6022	0.0206	0.7539
MDA-MB-415	HR+	Luminal	Sirolimus	MTOR	MTOR	1.33	uM	7510.068	0.5968	0.0084	0.7539
MDA-MB-415	HR+	Luminal	Sirolimus	MTOR	MTOR	6.67	uM	7510.068	0.6663	0.1672	0.7539
MDA-MB-415	HR+	Luminal	Sirolimus	MTOR	MTOR	33.3	uM	7510.068	0.6338	0.0924	0.7539
MDA-MB-415	HR+	Luminal	Sirolimus	MTOR	MTOR	167	uM	7510.068	0.6251	0.0726	0.7539
MDA-MB-415	HR+	Luminal	Sirolimus	MTOR	MTOR	0.0000853	uM	7512.069	1.0674	1.1561	0.8684
MDA-MB-415	HR+	Luminal	Sirolimus	MTOR	MTOR	0.000427	uM	7512.069	0.8870	0.7421	0.8684
MDA-MB-415	HR+	Luminal	Sirolimus	MTOR	MTOR	0.00213	uM	7512.069	0.7730	0.4870	0.8684
MDA-MB-415	HR+	Luminal	Sirolimus	MTOR	MTOR	0.0107	uM	7512.069	0.6528	0.2238	0.8684
MDA-MB-415	HR+	Luminal	Sirolimus	MTOR	MTOR	0.0533	uM	7512.069	0.6043	0.1198	0.8684
MDA-MB-415	HR+	Luminal	Sirolimus	MTOR	MTOR	0.267	uM	7512.069	0.6443	0.2055	0.8684
MDA-MB-415	HR+	Luminal	Sirolimus	MTOR	MTOR	1.33	uM	7512.069	0.6271	0.1687	0.8684
MDA-MB-415	HR+	Luminal	Sirolimus	MTOR	MTOR	6.67	uM	7512.069	0.5483	0.0012	0.8684
MDA-MB-415	HR+	Luminal	Sirolimus	MTOR	MTOR	33.3	uM	7512.069	0.4659	-0.1700	0.8684
MDA-MB-436	TNBC	Basal B	Sirolimus	MTOR	MTOR	0.000427	uM	7899.068	1.0738	1.0751	1.9316
MDA-MB-436	TNBC	Basal B	Sirolimus	MTOR	MTOR	0.00213	uM	7899.068	0.8451	0.8331	1.9316
MDA-MB-436	TNBC	Basal B	Sirolimus	MTOR	MTOR	0.0107	uM	7899.068	0.9231	0.9189	1.9316
MDA-MB-436	TNBC	Basal B	Sirolimus	MTOR	MTOR	0.0533	uM	7899.068	0.6493	0.5993	1.9316
MDA-MB-436	TNBC	Basal B	Sirolimus	MTOR	MTOR	0.267	uM	7899.068	0.7933	0.7740	1.9316
MDA-MB-436	TNBC	Basal B	Sirolimus	MTOR	MTOR	1.33	uM	7899.068	0.7168	0.6834	1.9316
MDA-MB-436	TNBC	Basal B	Sirolimus	MTOR	MTOR	6.67	uM	7899.068	0.8628	0.8529	1.9316
MDA-MB-436	TNBC	Basal B	Sirolimus	MTOR	MTOR	33.3	uM	7899.068	0.8666	0.8571	1.9316
MDA-MB-436	TNBC	Basal B	Sirolimus	MTOR	MTOR	167	uM	7899.068	0.4667	0.3480	1.9316
MDA-MB-453	TNBC	Luminal	Sirolimus	MTOR	MTOR	0.0000853	uM	7518.069	0.9832	0.9783	1.5543
MDA-MB-453	TNBC	Luminal	Sirolimus	MTOR	MTOR	0.000427	uM	7518.069	0.9284	0.9066	1.5543

|<
<<
Previous
Page 2681 of 3330
Next
>>
>
67001 to 67025 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)